XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer

  1. Feliu, J.
  2. Salud, A.
  3. Escudero, P.
  4. Lopez-Gómez, L.
  5. Bolaños, M.
  6. Galán, A.
  7. Vicent, J.-M.
  8. Yubero, A.
  9. Losa, F.
  10. De Castro, J.
  11. De Mon, M.Á.
  12. Casado, E.
  13. González-Barón, M.
Aldizkaria:
British Journal of Cancer

ISSN: 0007-0920,  1532-1827

Argitalpen urtea: 2006

Alea: 94

Zenbakia: 7

Orrialdeak: 969-975

Mota: Artikulua

DOI: 10.1038/SJ.BJC.6603047 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus